LexAurum Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
LexAurum Advisors's AMGN Position: Q2 2026 in Review
LexAurum Advisors increased its Amgen (AMGN) stake by 23% in Q2 2026, buying an estimated $107K and bringing the position to 1,695 shares worth $614K. The position accounts for 0.07% of the portfolio, ranked #215.
LexAurum Advisors first reported a position in AMGN in Q4 2019 and has held it in 25 quarters since. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- LexAurum Advisors held 1,695 shares of Amgen worth $614K as of Q2 2026.
- LexAurum Advisors bought 313 Amgen shares in Q2 2026, an estimated $107K.
- Amgen made up 0.07% of LexAurum Advisors's portfolio in Q2 2026, its #215 holding.
- LexAurum Advisors first reported a position in Amgen in Q4 2019 and has held it in 25 quarters since.
- 3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on LexAurum Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.